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Abstract 
 
To date, the laboratory has cloned seven unique human sulfotransferases; five aryl 
sulfotransferases (HAST1, HAST2, HAST3, HAST4 and HAST4v), an estrogen sulfotransferase 
and a dehydroepiandrosterone sulfotransferase. The cellular distribution of human aryl 
sulfotransferases in human hepatic and extrahepatic tissues has been determined using the 
techniques of hybridization histochemistry and immunohistochemistry. Human aryl 
sulfotransferase expression was detected in liver, epithelial cells of the gastrointestinal mucosal 
layer, epithelial cells lining bronchioles and in mammary duct epithelial cells. 
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Introduction 
 
Conjugation with sulfate is a major pathway involved in the disposition of a diverse range of chemicals including 
steroids, catecholamine neurotransmitters, alcohols, phenols, bile acids and arylamines. The enzymes responsible, 
sulfotransferases (STs), transfer a sulfonate moiety from 3%-phosphoadenosine-5%-phosphosulfate to the 
substrate’s functional group. In general, this process leads to detoxification of drugs but it can result in biological 
activation (e.g. minoxidil) or, in the case of N-hydroxy aromatic amines and N-hydroxy heterocyclic amines, the 
production of reactive electrophiles capable of binding to DNA [1]. 
Given the wide range of substrates available for sulfonation, it is not surprising that multiple forms of STs 
have been identified. In recent years, the field of ST study has expanded rapidly with numerous forms being cloned. 
At the present time, the cytosolic STs are classified into three separate families, the phenol STs, the hydroxysteroid 
STs and the flavonol STs. A comprehensive nomenclature system for the STs is currently under review and it has 
been proposed that forms possessing \45% amino acid sequence identity be classified as family members and those 
sharing \60% identity be further divided into subfamilies. Following these guidelines, the phenol ST family can be 
separated into two smaller groups, the phenol and estrogen ST subfamilies. For a more detailed description of this 
area, the reader is directed towards two reviews that summarise the current sulfotransferase supergene family [2,3]. 
 
Isolation of human aryl sulfotransferases 
 
To date, the laboratory has cloned five unique cytosolic human aryl sulfotransferases (HAST), HAST1, HAST2, 
HAST3, HAST4 and HAST4v. Initial studies in 1993 focused on the isolation and characterisation of a human aryl 
ST cDNA from a human liver cDNA library [4]. The cloning strategy in these early experiments involved the use of 
PCR primers designed from highly conserved regions of published ST cDNAs (bovine estrogen ST [5], rat aryl ST 
[6] and rat hydroxysteroid ST [7]). DNA isolated from a human liver cDNA library was used as template for the 
PCR reaction and the resulting 220 bp fragment was then employed in the screening of a human liver cDNA library. 
A full-length cDNA was isolated, sequenced and termed HAST1. The cloned HAST1 cDNA (1155 bp) shares 80% 
homology to the rat aryl ST, 58% to the bovine estrogen ST and 53% to the rat hydroxysteroid ST cDNAs over its 
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whole 885 bp coding domain. Northern blot analysis using HAST1 revealed the presence of strong bands in human 
liver and lung at a position of 1.7 kb and additional faint bands at a position of 1.2 kb [4]. 
Expanding on this initial study, the laboratory used DNA from a human brain cDNA library with the same 
primers used to isolate the HAST1 sequence [8]. The resultant PCR fragment was used to screen the brain library 
and two different full length cDNAs (HAST2 and HAST3) were isolated and sequenced. HAST2 is 1179 bp in 
length, has the same coding region as HAST1 but differs in 34 bp at the 5% end of the cDNA. The influence of the 
5% end differences between HAST1 and HAST2 cDNAs and possible tissue specific regulation has yet to be 
elucidated. It should be noted that another brain ST, hippocampal phenol ST [9], and HAST2 share similar 5% 
untranslated nucleotide sequences. The second human brain cDNA that was isolated in the laboratory, HAST3 (1424 
bp), shares 90, 48, 58 and 53% homology to HAST1, human alcohol:hydroxysteroid ST [10], human estrogen ST 
and bovine estrogen ST, respectively. Northern blot analysis of human liver, colon, kidney, lung and hepatocellular 
carcinoma mRNA with a 221 bp DNA fragment from the 3% non-coding region of HAST3 demonstrated the 
presence of a strong band at a position of 1.5 kb in all of the tissues examined. An additional band of approximately 
3.3 kb was detected in the hepatocellular carcinoma mRNA, the identity and significance of which is currently 
unknown. The coding region for HAST3 is 885 bp in length and shares 93% identity with HAST1 and HAST2 [8]. 
Another partial HAST cDNA (HAST4) was isolated in the laboratory using the HAST3 cDNA to screen a 
human brain library. Despite repeated attempts to clone the full length cDNA, the brain HAST4 cDNA was found to 
lack 370 bp of the coding region at the 5% end [11]. The successful isolation of full-length HAST4 (1036 bp) and 
HAST4v (1060 bp) sequences was achieved from a human liver library using a partial HAST4 cDNA. HAST4 and 
HAST4v share an open reading frame length of 885 bp but differ by 3 nucleotides that translates into two amino 
acid differences (Thr-7 to Ile and Thr-235 to Asn). The coding domains of HAST4 and HAST4v are 97 and 94% 
homologous to HAST1 and HAST3, respectively. 
 
Localisation of human aryl sulfotransferases 
 
Functional assays performed in the laboratory using COS cell-expressed HAST protein have demonstrated that 
HAST1 preferentially sulfonates p-nitrophenol whilst HAST3 catalyses the sulfonation of dopamine [12]. In 
contrast, HAST4 and HAST4v possess intermediate phenol-sulfonating ability and do not display any activity 
towards dopamine [11]. The aryl STs clearly have distinct substrate specificities but their high level of sequence 
homology makes cellular localisation of a specific form difficult. Numerous metabolic and immunohistochemical 
studies have indicated the presence of STs in a wide range of tissues including liver, lung, brain, skin, platelets, 
gastrointestinal tissues, kidney and breast [13–18] but the lack of probes or antibodies specific for the various forms 
has hindered the progress of detailed studies of tissue localisation. 
In the present study, the techniques of hybridisation histochemistry and immunohistochemistry have been 
utilised in paraffin-embedded, formalin-fixed human tissues to gain insight into the cellular distribution of HAST1 
and HAST3. The full length (1155 bp) HAST1 cDNA and a 198 bp PCR fragment from the 3% end of the 
untranslated region of HAST3 were subcloned into the Bluescript SK transcription plasmid. For both HAST1 and 
HAST3, antisense and sense riboprobes were transcribed for use as test and control probes, respectively. The 
HAST1 probe was hydrolysed to 250 bp under alkaline conditions prior to hybridisation. Previous blotting 
experiments have shown that the HAST3 probe is specific but the full length HAST1 probe detects all of the human 
aryl STs with HAST1 being the predominant form identified. HAST1 mRNA expression was displayed throughout 
the liver (Fig. 1) but only very low levels of HAST3 hepatic mRNA could be detected. Within the gastrointestinal 
tract, the surface epithelial cells of the mucosa and the epithelial cells of the crypts of Lieberkuhn demonstrated 
positive signal with both HAST probes (Fig. 2). In the lung, HAST1 and HAST3 mRNA expression was localised to 
bronchial epithelial cells whilst in breast tissue, the expression of both HAST1 and HAST3 mRNA was low. 
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 For immunohistochemical studies, an antibody raised against the partial HAST1 sequence (amino acids 31–286) 
was used. Previous immunoblot experiments using COS-expressed protein have shown that the antibody detects all 
HAST proteins with HAST1 being the predominant protein detected. In the liver, HAST protein was distributed 
evenly throughout the acinus whilst in gastrointestinal tissues, the surface epithelial cells of the mucosa displayed 
strongest signal. Bronchial epithelial cells and mammary duct epithelial cells also exhibited positive 
immunochemical staining. The development of riboprobes:oligoprobes and peptide antibodies specific for the 
various forms of aryl STs will allow a more exacting study of their localisation to be performed and this is currently 
being addressed. The results presented here demonstrate the presence of aryl STs in a range of human tissues and 
their expression in diseased tissues is also now under investigation. 
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